Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_29080738c6d4e90aa75a7a0ab3a50f88 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-855 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-815 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-815 |
filingDate |
1991-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1993-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97324f94608d2e531f72d2021d16d62f |
publicationDate |
1993-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-5194589-A |
titleOfInvention |
Leech protein having anticoagulant and antimetastatic properties |
abstract |
The present invention comprises a biochemically pure protein, termed antistasin, which exhibits both antimetastatic and anticoagulant properties. Methods of producing the protein and methods of using the protein to inhibit or reduce metastasis and/or coagulation of blood are disclosed. The complete amino acid sequences of antistasin and some variants have been determined from purified protein and cloned cDNAs. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5976841-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7691839-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8188034-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011034396-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007099819-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107177654-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010129419-A1 |
priorityDate |
1986-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |